UK-based medicine delivery platform Pharmacierge has raised £2.4 million in a funding round which saw private clinicians and app users make up 90% of the funding. The round also includes new and repeat investments from current or former Managing Directors at Goldman Sachs, Merrill/Bank of America, Citigroup and Tullett Prebon.
“This latest round represents a profound and unique endorsement of Pharmacierge by the very same consultants and GPs who use it most often. They’ve recognised the huge value in our product, and have not only validated that as users, but also as investors,” says Pharmacierge co-founder and CEO Edward Ungar.
Using electronic prescription (EPS) and dispensary management (ERP) systems, Pharmacierge’s clinician-facing app, mPrescribe, deals with the compliance and industry regulations whilst handling courier delivery from its large dispensary. The investment will be used to power its next phase of growth combining dispensing robotics with AI.
"Having long experienced the time-saving benefits that the Pharmacierge service offers clinicians and patients, it was a simple decision to invest in a business that I both understood and trusted," says Dr Stephanie Barrett, Consultant Rheumatologist.